BioLight Life Sciences Ltd. (BOLT.TA)

ILA 642.0

(1.28%)

Net Debt Summary of BioLight Life Sciences Ltd.

BioLight Life Sciences Ltd.'s latest annual net debt in 2023 was -5.27 Million ILS , up 59.7% from previous year.
BioLight Life Sciences Ltd.'s latest quarterly net debt in 2024 Q2 was -1.36 Million ILS , down 0.0% from previous quarter.
BioLight Life Sciences Ltd. reported annual net debt of -12.86 Million ILS in 2022, up 61.04% from previous year.
BioLight Life Sciences Ltd. reported annual net debt of -33.02 Million ILS in 2021, down -13.64% from previous year.
BioLight Life Sciences Ltd. reported quarterly net debt of -5.27 Million ILS for 2023 Q4, down 0.0% from previous quarter.
BioLight Life Sciences Ltd. reported quarterly net debt of -8.65 Million ILS for 2023 Q2, down 0.0% from previous quarter.

Annual Net Debt Chart of BioLight Life Sciences Ltd. (2023 - 2013)

Historical Annual Net Debt of BioLight Life Sciences Ltd. (2023 - 2013)

Year	Net Debt	Net Debt Growth
2023	-5.27 Million ILS	59.7%
2022	-12.86 Million ILS	61.04%
2021	-33.02 Million ILS	-13.64%
2020	-29.05 Million ILS	16.73%
2019	-34.89 Million ILS	18.96%
2018	-43.05 Million ILS	-180.42%
2017	-15.35 Million ILS	39.72%
2016	-25.47 Million ILS	49.75%
2015	-50.69 Million ILS	-128.41%
2014	-22.19 Million ILS	-25.29%
2013	-17.71 Million ILS	0.0%

Year	Net Debt	Net Debt Growth
2024 Q2	-1.36 Million ILS	0.0%
2023 Q4	-5.27 Million ILS	0.0%
2023 Q2	-8.65 Million ILS	0.0%
2023 FY	-5.27 Million ILS	58.99%
2022 Q4	-12.86 Million ILS	0.0%
2022 Q2	-7.64 Million ILS	0.0%
2022 FY	-12.86 Million ILS	61.04%
2021 Q2	-40.27 Million ILS	0.0%
2021 Q4	-33.46 Million ILS	0.0%
2021 FY	-33.02 Million ILS	-13.64%
2020 Q4	-29.05 Million ILS	-12.89%
2020 Q1	-34.02 Million ILS	2.51%
2020 Q3	-25.74 Million ILS	10.85%
2020 FY	-29.05 Million ILS	16.73%
2020 Q2	-28.87 Million ILS	15.12%
2019 Q4	-34.89 Million ILS	20.03%
2019 FY	-34.89 Million ILS	18.96%
2019 Q3	-43.63 Million ILS	-25.58%
2019 Q2	-34.74 Million ILS	-39.68%
2019 Q1	-24.87 Million ILS	42.23%
2018 Q4	-43.05 Million ILS	9.54%
2018 FY	-43.05 Million ILS	-180.42%
2018 Q3	-47.6 Million ILS	-22.71%
2018 Q2	-38.79 Million ILS	-16.57%
2018 Q1	-33.27 Million ILS	-116.72%
2017 Q3	-19.97 Million ILS	20.4%
2017 FY	-15.35 Million ILS	39.72%
2017 Q1	-19.84 Million ILS	22.11%
2017 Q2	-25.09 Million ILS	-26.46%
2017 Q4	-15.35 Million ILS	23.12%
2016 FY	-25.47 Million ILS	49.75%
2016 Q4	-25.47 Million ILS	19.9%
2016 Q3	-31.8 Million ILS	13.23%
2016 Q2	-36.65 Million ILS	13.18%
2016 Q1	-42.22 Million ILS	16.72%
2015 Q3	-36.71 Million ILS	13.95%
2015 Q4	-50.69 Million ILS	-38.08%
2015 Q2	-42.66 Million ILS	0.0%
2015 FY	-50.69 Million ILS	-128.41%
2014 FY	-22.19 Million ILS	-25.29%
2014 Q4	-22.19 Million ILS	0.0%
2014 Q2	-21.84 Million ILS	0.0%
2013 Q2	-31.24 Million ILS	0.0%
2013 Q4	-17.71 Million ILS	0.0%
2013 FY	-17.71 Million ILS	0.0%

Peer Net Debt Comparison of BioLight Life Sciences Ltd.

Name	Net Debt	Net Debt Difference
Matricelf Ltd	-835 Thousand ILA	-531.856%